Holen Sie sich die Stockscreener-App
9.29
0.54%
-0.05
Schlusskurs vom Vortag:
$9.34
Offen:
$9.42
24-Stunden-Volumen:
76,551
Relative Volume:
0.43
Marktkapitalisierung:
$122.19M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00263
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
-5.97%
1M Leistung:
+42.05%
6M Leistung:
+40.76%
1J Leistung:
+2.65%
1-Tages-Spanne:
$9.10
$9.6999
1-Wochen-Bereich:
$9.10
$9.9362
52-Wochen-Spanne:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Vergleichen Sie AVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
9.29 | 122.84M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Jefferies | Buy |
| 2025-03-25 | Eingeleitet | Stifel | Buy |
| 2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
Will Avalo Therapeutics Inc. bounce back from current supportPortfolio Return Summary & Accurate Entry/Exit Alerts - Newser
What Technical Tools Say About Avalo Therapeutics Inc. Recovery getLinesFromResByArray error: size == 0 - thegnnews.com
Real time scanner hits for Avalo Therapeutics Inc. explained2025 Momentum Check & Low Drawdown Trading Strategies - Newser
Analyzing recovery setups for Avalo Therapeutics Inc. investorsWeekly Market Outlook & Weekly High Return Stock Opportunities - Newser
Is Avalo Therapeutics Inc. trending in predictive chart models2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - Newser
Should you hold or exit Avalo Therapeutics Inc. now2025 Market WrapUp & Precise Buy Zone Identification - Newser
Will Avalo Therapeutics Inc. benefit from macro trends2025 Key Highlights & Smart Money Movement Alerts - Newser
Custom strategy builders for tracking Avalo Therapeutics Inc.2025 Price Action Summary & Low Risk Entry Point Tips - Newser
Is Avalo Therapeutics Inc. still worth holding after the dip2025 Market WrapUp & Daily Profit Maximizing Trade Tips - Newser
How to forecast Avalo Therapeutics Inc. trends using time seriesJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
News impact scoring models applied to Avalo Therapeutics Inc.Insider Buying & Real-Time Volume Analysis Alerts - Newser
Avalo Therapeutics Inc. stock outlook for YEARGap Down & Detailed Earnings Play Alerts - Newser
How to read the order book for Avalo Therapeutics Inc.Entry Point & Safe Capital Investment Plans - Newser
Will Avalo Therapeutics Inc. Sustain Its Chart Breakout getLinesFromResByArray error: size == 0 - newsyoung.net
Can swing trading help recover from Avalo Therapeutics Inc. lossesForecast Cut & Daily Technical Forecast Reports - Newser
How institutional ownership impacts Avalo Therapeutics Inc. stockWeekly Stock Report & Real-Time Sentiment Analysis - Newser
Is Avalo Therapeutics Inc. forming a bottoming baseMarket Growth Review & High Accuracy Buy Signal Tips - Newser
Avalo Therapeutics Inc. stock momentum explainedEarnings Beat & High Conviction Buy Zone Picks - Newser
Is Avalo Therapeutics Inc. likely to announce a buybackTrade Analysis Report & AI Optimized Trading Strategy Guides - sundaytimes.kr
How to track smart money flows in Avalo Therapeutics Inc.Trade Volume Report & Short-Term High Return Ideas - Newser
Using RSI to spot recovery in Avalo Therapeutics Inc.Portfolio Value Summary & Weekly Setup with High ROI Potential - Newser
Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):